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The nonnal endothelium is in a non-activated state evidenced by its inability to support leukocyte 
adhesion and its lack of angiogenesis. I present evidence in this thesis that the intracellular levels 
and activity of Sphingosine Kinase (SK) regulate the inflammatory potential of the endothelium 
and are also an important detenninant of the ability of the endothelium to undergo angiogenesis. 
Moderate (three to fivefold) elevations in SK activity in human umbilical vein endothelial cells 
resulted in endothelial activation, as indicated by the heightened expression of adhesion 
molecules, and further sensitized the cells to subliminal doses of inflammatory cytokines. This 
corresponded with enhanced neutrophil binding in the un-stimulated and stimulated states. Over­
expression of a dominant-negative SK (G82D, containing the substitution glycine to aspartate 
and which blocks agonist-induced activation of SK) inhibited the adhesion molecule response to 
inflammatory cytokine and inhibited leukocyte adhesion. Over-expression of SK increased cell 
survival under the stressful conditions of serum deprivation and loss of attachment with 
extracellular matrix, which was associated with suppression of apoptotic mechanisms. Raised SK 
activity also stimulated cell migration and cellular remoaeling, additional measures of 
angiogenesis. Over-expression of SK enabled activation of the phosphatidyl inositol-3kinase (PI­
3K1Akt) pathway in response to serum deprivation, and this pathway was obligatory in mediating 
SK-induced cell survival. Activation of the PI-3K1Akt pathway in cells with raised SK activity 
was mediated by the cell junctional molecule platelet endothelial cell adhesion molecule-l 
(PECAM-l), which was upregulated and dephosphorylated and critical in SK-induced cell 
survival. Thus raised intracellular SK activity enables a PECAM-l-dependent activation of the 
PI-3K1Akt pathway to augment cell survival, thus exposing a hitherto unexplored pathway of 
endothelial cell survival which may be manipulated therapeutically_ The findings suggest a 
possible role for SK levels in the regulation of angiogenic phenomena as well as in the capacity 
Front 
of endothelial cells to survive in suspension (circulating endothelial cells). Thus SK could be 
considered as a novel target for therapeutic manipulation in diseases of aberrant inflammation 
and angiogenesis. 
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